Saturday 17 October 2026 Export UTHR’s income statement to Excel — free account

United Therapeutics Corporation

UTHR Healthcare Drug Manufacturers Specialty & Generic

United Therapeutics Corporation’s revenue for fiscal 2025 (year ended December 2025) was $3.2 billion, up 10.6% from fiscal 2024. In the quarter to June 2026, revenue fell 1.92%, EPS grew 14.0% and free cash flow grew 58.8%, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for three; insiders bought in the last twelve months.

533.12 8.39 −1.55%

Follow UTHR

Alert me

Market cap: $23.2B
P/E: 17.6×
Fwd P/E: 20.1×
Dividend yield: —
F-score: 8/9
Altman Z: 19.55
Beneish M: −2.26
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
P/E ratio Full definition →	+8 more quarters Free account	14.70	16.14	20.22	17.89
P/S ratio Full definition →		5.87	6.78	8.14	7.32
P/FCF ratio Full definition →		16.52	20.85	25.50	21.22
P/Operating CF Full definition →		32.67	62.35	55.68	73.60
P/B ratio Full definition →		2.79	3.04	4.37	3.61
Price to Tangible BV Full definition →		2.84	3.09	4.46	3.67
EV/Sales Full definition →		5.08	5.96	7.55	6.57
EV/EBITDA Full definition →		10.08	12.02	15.71	13.88
EV/Operating CF Full definition →		10.21	12.15	15.31	12.30
EV/FCF Full definition →		14.30	18.32	23.67	19.05
Quick Ratio Full definition →		5.61	5.83	4.12	4.89
Current Ratio Full definition →		6.40	6.60	4.79	5.73
Net Debt/EBITDA Full definition →		(6.74)	(7.70)	(6.18)	(7.50)
Debt/Assets Full definition →		0.00%	0.00%	0.00%	0.00%
Debt/Equity Full definition →		0.00	0.00	0.00	0.00
Asset Turnover Full definition →		0.43	0.42	0.44	0.42
Operating CF/Net income Full definition →		1.66	0.95	1.69	0.94
Capex/Depreciation Full definition →		(9.86)	(7.58)	(4.46)	(4.46)
Interest Coverage Full definition →		129.50	115.06	108.60	114.07
Research and Development Expense of Revenue Full definition →		15.95%	17.65%	17.68%	18.68%
Selling, General and Administrative Expense of Revenue Full definition →		22.84%	24.12%	23.56%	26.39%
Intangible Assets out of Total Assets Full definition →		0.02	0.01	0.02	0.02
Share Based Compensation of Revenue Full definition →		4.89%	4.94%	4.34%	5.54%
Graham Net Nets Full definition →		0.15	0.14	0.08	0.12
Graham Number Full definition →		310.67	329.81	299.15	319.94
Earnings Yield Full definition →		6.80%	6.19%	4.94%	5.59%
Free Cash Flow Yield Full definition →		6.05%	4.80%	3.92%	4.71%
Revenue per Share Full definition →		18.25	17.84	17.97	18.39
Operating CF per Share Full definition →		12.83	7.81	10.65	7.36
Capex per Share Full definition →		(4.93)	(3.90)	(2.32)	(2.54)
Free Cash Flow per Share Full definition →		7.90	3.91	8.33	4.83
Cash per Share Full definition →		63.19	65.92	49.51	62.50
Shareholders Equity per Share Full definition →		150.46	160.19	135.66	150.24
Interest Debt per Share Full definition →		0.00	0.00	0.00	0.00
Book value per Share Full definition →		150.46	160.19	135.66	150.24
Free Cash Flow Full definition →		346.10	173.30	362.50	205.60
Working Capital Full definition →		2,947.70	3,141.90	2,272.90	2,875.90
Capital Expenditures Full definition →		(216.00)	(172.90)	(100.80)	(108.00)
Net Current Asset Value Full definition →		2,733.10	2,918.70	2,058.90	2,663.90
EV/EBIT Full definition →		10.64	12.71	16.68	14.78
Capex to Sales Full definition →		0.27	0.22	0.13	0.14
Price to Operating Income Full definition →		12.29	14.46	17.97	16.47
Other line items
Average Receivables Full definition →		319.75	314.75	317.00	344.80
Average Payables Full definition →		415.95	416.25	432.65	464.90
Average Inventory Full definition →		161.60	170.50	171.85	181.50
Average Assets Full definition →		7,237.10	7,622.00	7,229.05	7,564.05
Average Common Equity Full definition →		6,345.55	6,770.10	6,354.15	6,786.95

Show all line items

Columns are period end dates

Stockrow Weekly